Latest news
Loading news…
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
IVERIC bio was acquired by Astellas Pharma in 2023 for $6B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Princeton, New Jersey, United States
Key People at IVERIC bio
President and CEO, Member of the Board of Directors
Director
Chief Clinical Operations Officer
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to IVERIC bio
Loading news…
FAQs about IVERIC bio
People who checked this page also checked these
Browse the full Acquirezy directory.